Titre : Cellules A549

Cellules A549 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Visualization
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cellules A549 : Questions médicales les plus fréquentes", "headline": "Cellules A549 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cellules A549 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-28", "dateModified": "2025-03-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cellules A549" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cellules épithéliales", "url": "https://questionsmedicales.fr/mesh/D004847", "about": { "@type": "MedicalCondition", "name": "Cellules épithéliales", "code": { "@type": "MedicalCode", "code": "D004847", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.436" } } }, "about": { "@type": "MedicalCondition", "name": "Cellules A549", "alternateName": "A549 Cells", "code": { "@type": "MedicalCode", "code": "D000072283", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Wenfei Zhao", "url": "https://questionsmedicales.fr/author/Wenfei%20Zhao", "affiliation": { "@type": "Organization", "name": "Department of Respiratory, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China." } }, { "@type": "Person", "name": "Hongyun Li", "url": "https://questionsmedicales.fr/author/Hongyun%20Li", "affiliation": { "@type": "Organization", "name": "Department of Respiratory, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China." } }, { "@type": "Person", "name": "Shanshan Yang", "url": "https://questionsmedicales.fr/author/Shanshan%20Yang", "affiliation": { "@type": "Organization", "name": "Department of Respiratory, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China." } }, { "@type": "Person", "name": "Di Guo", "url": "https://questionsmedicales.fr/author/Di%20Guo", "affiliation": { "@type": "Organization", "name": "Department of Respiratory, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China." } }, { "@type": "Person", "name": "Jing Chen", "url": "https://questionsmedicales.fr/author/Jing%20Chen", "affiliation": { "@type": "Organization", "name": "Department of Respiratory, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A Deep Learning Approach to Visualize Aortic Aneurysm Morphology Without the Use of Intravenous Contrast Agents.", "datePublished": "2023-01-10", "url": "https://questionsmedicales.fr/article/33913675", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/SLA.0000000000004835" } }, { "@type": "ScholarlyArticle", "name": "Nondestructive testing and visualization of compound heavy metals in lettuce leaves using fluorescence hyperspectral imaging.", "datePublished": "2023-01-07", "url": "https://questionsmedicales.fr/article/36680832", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.saa.2023.122337" } }, { "@type": "ScholarlyArticle", "name": "SCORE2 Report 20: Relationship of Treatment Discontinuation With Visual Acuity and Central Subfield Thickness Outcomes.", "datePublished": "2022-12-28", "url": "https://questionsmedicales.fr/article/36584835", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajo.2022.12.026" } }, { "@type": "ScholarlyArticle", "name": "Distinguishing guesses from fuzzy memories: Further evidence for item limits in visual working memory.", "datePublished": "2022-12-20", "url": "https://questionsmedicales.fr/article/36539572", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3758/s13414-022-02631-y" } }, { "@type": "ScholarlyArticle", "name": "Visual performance and impact of residual refractive errors with trifocal intraocular lenses of different aspheric design.", "datePublished": "2022-12-18", "url": "https://questionsmedicales.fr/article/36529873", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/11206721221144928" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Cellules épithéliales", "item": "https://questionsmedicales.fr/mesh/D004847" }, { "@type": "ListItem", "position": 4, "name": "Cellules A549", "item": "https://questionsmedicales.fr/mesh/D000072283" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cellules A549 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cellules A549", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cellules A549", "description": "Comment identifier les cellules A549 en laboratoire ?\nQuelles techniques sont utilisées pour étudier les cellules A549 ?\nLes cellules A549 sont-elles tumorales ?\nPeut-on détecter des marqueurs spécifiques dans les A549 ?\nLes cellules A549 sont-elles sensibles à des médicaments ?", "url": "https://questionsmedicales.fr/mesh/D000072283?mesh_terms=Data+Visualization&page=998#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cellules A549", "description": "Quels symptômes sont associés aux cellules A549 ?\nLes cellules A549 peuvent-elles simuler des symptômes humains ?\nComment les A549 aident-elles à comprendre les symptômes du cancer ?\nLes cellules A549 montrent-elles des signes de stress cellulaire ?\nPeut-on observer des symptômes de résistance dans les A549 ?", "url": "https://questionsmedicales.fr/mesh/D000072283?mesh_terms=Data+Visualization&page=998#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cellules A549", "description": "Les cellules A549 aident-elles à la prévention du cancer ?\nComment les A549 contribuent-elles à la recherche préventive ?\nPeut-on utiliser les A549 pour étudier des facteurs de risque ?\nLes A549 sont-elles utiles pour la recherche sur le tabagisme ?\nComment les A549 aident-elles à comprendre la prévention des maladies ?", "url": "https://questionsmedicales.fr/mesh/D000072283?mesh_terms=Data+Visualization&page=998#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cellules A549", "description": "Quels traitements sont testés sur les cellules A549 ?\nLes A549 sont-elles utilisées pour des essais cliniques ?\nComment les A549 aident-elles à développer de nouveaux traitements ?\nLes cellules A549 peuvent-elles prédire la réponse au traitement ?\nQuels agents sont souvent testés sur les A549 ?", "url": "https://questionsmedicales.fr/mesh/D000072283?mesh_terms=Data+Visualization&page=998#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cellules A549", "description": "Quelles complications peuvent être étudiées avec les A549 ?\nLes A549 peuvent-elles simuler des complications pulmonaires ?\nComment les A549 aident-elles à comprendre les complications du cancer ?\nPeut-on étudier la résistance aux traitements avec les A549 ?\nLes A549 sont-elles impliquées dans des complications métaboliques ?", "url": "https://questionsmedicales.fr/mesh/D000072283?mesh_terms=Data+Visualization&page=998#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cellules A549", "description": "Quels facteurs de risque sont étudiés avec les A549 ?\nLes A549 aident-elles à identifier des facteurs génétiques ?\nComment les A549 sont-elles utilisées pour étudier l'environnement ?\nPeut-on étudier l'alimentation avec les A549 ?\nLes A549 sont-elles utiles pour étudier le stress oxydatif ?", "url": "https://questionsmedicales.fr/mesh/D000072283?mesh_terms=Data+Visualization&page=998#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les cellules A549 en laboratoire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les cellules A549 peuvent être identifiées par leur morphologie et leur croissance en culture." } }, { "@type": "Question", "name": "Quelles techniques sont utilisées pour étudier les cellules A549 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les techniques incluent la microscopie, la cytométrie en flux et les tests de viabilité cellulaire." } }, { "@type": "Question", "name": "Les cellules A549 sont-elles tumorales ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les cellules A549 proviennent d'un adénocarcinome, ce qui les rend tumorales." } }, { "@type": "Question", "name": "Peut-on détecter des marqueurs spécifiques dans les A549 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des marqueurs comme le CD44 et le p53 peuvent être analysés dans les A549." } }, { "@type": "Question", "name": "Les cellules A549 sont-elles sensibles à des médicaments ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour tester la sensibilité aux chimiothérapies." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux cellules A549 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les cellules A549 ne présentent pas de symptômes, car elles sont in vitro." } }, { "@type": "Question", "name": "Les cellules A549 peuvent-elles simuler des symptômes humains ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être utilisées pour étudier des symptômes liés aux maladies pulmonaires." } }, { "@type": "Question", "name": "Comment les A549 aident-elles à comprendre les symptômes du cancer ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'étudier la réponse des cellules tumorales aux traitements et aux facteurs de croissance." } }, { "@type": "Question", "name": "Les cellules A549 montrent-elles des signes de stress cellulaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent montrer des signes de stress en réponse à des agents cytotoxiques." } }, { "@type": "Question", "name": "Peut-on observer des symptômes de résistance dans les A549 ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être utilisées pour étudier la résistance aux médicaments anticancéreux." } }, { "@type": "Question", "name": "Les cellules A549 aident-elles à la prévention du cancer ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, elles sont utilisées pour étudier les mécanismes de la carcinogenèse." } }, { "@type": "Question", "name": "Comment les A549 contribuent-elles à la recherche préventive ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'identifier des biomarqueurs et des cibles pour la prévention du cancer." } }, { "@type": "Question", "name": "Peut-on utiliser les A549 pour étudier des facteurs de risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont utilisées pour étudier l'impact de divers facteurs environnementaux sur le cancer." } }, { "@type": "Question", "name": "Les A549 sont-elles utiles pour la recherche sur le tabagisme ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour étudier les effets du tabagisme sur les cellules pulmonaires." } }, { "@type": "Question", "name": "Comment les A549 aident-elles à comprendre la prévention des maladies ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'explorer les mécanismes de protection et les interventions préventives." } }, { "@type": "Question", "name": "Quels traitements sont testés sur les cellules A549 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements anticancéreux et les thérapies ciblées sont souvent testés sur ces cellules." } }, { "@type": "Question", "name": "Les A549 sont-elles utilisées pour des essais cliniques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles sont utilisées pour des études précliniques et non pour des essais cliniques directs." } }, { "@type": "Question", "name": "Comment les A549 aident-elles à développer de nouveaux traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'évaluer l'efficacité et la toxicité des nouveaux composés thérapeutiques." } }, { "@type": "Question", "name": "Les cellules A549 peuvent-elles prédire la réponse au traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent fournir des indications sur la réponse aux traitements, mais ne sont pas définitives." } }, { "@type": "Question", "name": "Quels agents sont souvent testés sur les A549 ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des agents chimiothérapeutiques comme le cisplatine et des inhibiteurs de tyrosine kinase." } }, { "@type": "Question", "name": "Quelles complications peuvent être étudiées avec les A549 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'étudier les complications liées aux traitements du cancer et aux métastases." } }, { "@type": "Question", "name": "Les A549 peuvent-elles simuler des complications pulmonaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont utilisées pour modéliser des complications comme la fibrose pulmonaire." } }, { "@type": "Question", "name": "Comment les A549 aident-elles à comprendre les complications du cancer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'étudier les interactions entre les cellules tumorales et le microenvironnement." } }, { "@type": "Question", "name": "Peut-on étudier la résistance aux traitements avec les A549 ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour comprendre les mécanismes de résistance aux traitements." } }, { "@type": "Question", "name": "Les A549 sont-elles impliquées dans des complications métaboliques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être utilisées pour étudier les effets métaboliques des traitements anticancéreux." } }, { "@type": "Question", "name": "Quels facteurs de risque sont étudiés avec les A549 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme le tabagisme, l'exposition à des agents chimiques et la pollution." } }, { "@type": "Question", "name": "Les A549 aident-elles à identifier des facteurs génétiques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être utilisées pour étudier l'expression génique liée à des prédispositions au cancer." } }, { "@type": "Question", "name": "Comment les A549 sont-elles utilisées pour étudier l'environnement ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'évaluer l'impact des toxines environnementales sur les cellules pulmonaires." } }, { "@type": "Question", "name": "Peut-on étudier l'alimentation avec les A549 ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, elles peuvent être utilisées pour explorer l'impact des nutriments sur le cancer." } }, { "@type": "Question", "name": "Les A549 sont-elles utiles pour étudier le stress oxydatif ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour examiner les effets du stress oxydatif sur les cellules." } } ] } ] }

Sources (10000 au total)

A Deep Learning Approach to Visualize Aortic Aneurysm Morphology Without the Use of Intravenous Contrast Agents.

Intravenous contrast agents are routinely used in CT imaging to enable the visualization of intravascular pathology, such as with abdominal aortic aneurysms. However, the injection is contraindicated ... In this study, we investigate if the raw data acquired from a noncontrast CT image contains sufficient information to differentiate blood and other soft tissue components. A deep learning pipeline und... Two generative models (cycle- and conditional) are trained with paired noncontrast and contrast enhanced CTs from seventy-five patients (total of 11,243 pairs of images) with abdominal aortic aneurysm... This pipeline implements deep learning methods to generate CTAs from noncontrast images, without the need of contrast injection, that bear strong concordance to the ground truth and enable the assessm...

SCORE2 Report 20: Relationship of Treatment Discontinuation With Visual Acuity and Central Subfield Thickness Outcomes.

To investigate the relationship of anti-vascular endothelial growth factor (anti-VEGF) treatment discontinuation with baseline factors and outcomes in eyes treated initially with aflibercept or bevaci... Long-term follow-up after a randomized clinical trial from 64 US centers.... Analysis included 150 SCORE2 Month 60 completers classified into 3 groups: discontinued treatment early, treated intermittently, and treated continuously. Outcomes included visual acuity (VA) and cent... Patients who discontinued treatment early were younger (60.9 years, vs 66.7 and 70.5 for the treated intermittently and treated continuously groups; P = .001), and 17.4% were Black, compared to 19.5% ... Compared to those treated continuously, those who discontinued treatment early were younger and more likely Black. The discontinued treatment early group had a higher proportion with complete resoluti...

Visual performance and impact of residual refractive errors with trifocal intraocular lenses of different aspheric design.

To assess the visual quality and the tolerance to low refractive errors of two trifocal intraocular lenses (IOL) with different amounts of spherical aberration (SA).... The study included patients having bilateral implantation of the AcrySof® IQ PanOptix... This study included 54 eyes (28 with PanOptix and 26 with RayOne) of 27 patients. Both groups achieved corrected/uncorrected and monocular/binocular distance VA values better than 0.0 logMAR (1.0 deci... Both lenses showed overall good visual outcomes and offered high rates of patient's satisfaction. Moreover, in normal patients with trifocal IOLs, the combination of residual refractive errors and cer...

Psychophysical Evaluation of Visual vs. Computer-Aided Detection of Brain Lesions on Magnetic Resonance Images.

Magnetic resonance imaging (MRI) diagnosis is usually performed by analyzing contrast-weighted images, where pathology is detected once it reached a certain visual threshold. Computer-aided diagnosis ... To compare conventional (i.e., visual) MRI assessment of artificially generated multiple sclerosis (MS) lesions in the brain's white matter to CAD based on a deep neural network.... Prospective.... A total of 25 neuroradiologists (15 males, age 39 ± 9, 9 ± 9.8 years of experience) independently assessed all synthetic lesions.... A 3.0 T, T... MS lesions of varying severity levels were artificially generated in healthy volunteer MRI scans by manipulating T... Diagnostic performance of the two approaches was compared using z-tests on TP rates, FP rates, and the logarithm of ORs across severity levels. A P-value <0.05 was considered statistically significant... ORs of identifying pathology were significantly higher for CAD vis-à-vis visual inspection for all lesions' severity levels. For a 6% change in T... CAD is capable of detecting the presence or absence of more subtle lesions with greater precision than the representative group of 25 radiologists chosen in this study.... 1 TECHNICAL EFFICACY: Stage 3....

A visualized dynamic prediction model for survival of patients with geriatric thyroid cancer: A population-based study.

Thyroid cancer (TC) is a common malignancy with a poor prognosis with aging. However, no accurate predictive survival model exists for patients with geriatric TC.We aimed to establish prediction model... We retrospectively reviewed the clinicopathology characteristics of patients with geriatric TC in the Surveillance, Epidemiology, and End Results database (SEER) from 2004 to 2018. The risk predictors... We used the SEER database to include 16475 patients with geriatric TC diagnosed from 2004 to 2018. The patients from 2004 to 2015 were randomly sorted out on a scale of 7:3. They were classified into ... This was the first study to construct predictive survival nomograms for patients with geriatric TC. The well-established nomograms and the actual results could guide follow-up management strategies....